selenocysteine and Osteogenic Sarcoma

selenocysteine has been researched along with Osteogenic Sarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, X; Meng, FB; Wang, W; Wang, ZX; Zhou, DS1
Guo, HH; Huang, G; Li, JC; Shen, JN; Xu, MH; Yong, BC1

Other Studies

2 other study(ies) available for selenocysteine and Osteogenic Sarcoma

ArticleYear
Selenocysteine inhibits human osteosarcoma cells growth through triggering mitochondrial dysfunction and ROS-mediated p53 phosphorylation.
    Cell biology international, 2018, Volume: 42, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Mice, Nude; Mitochondria; Osteosarcoma; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Selenocysteine; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018
Analysis of Selenium Levels in Osteosarcoma Patients and the Effects of Se-Methylselenocysteine on Osteosarcoma Cells In Vitro.
    Nutrition and cancer, 2015, Volume: 67, Issue:5

    Topics: Adolescent; Adult; Aged; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Child; Drug Evaluation, Preclinical; Female; Genes, bcl-2; Humans; Male; Middle Aged; Osteosarcoma; Selenium; Selenocysteine; Young Adult

2015